Published Date: March 2024
The report "Aptamers Market, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), By Application (Diagnostics, Therapeutics, and Research and Development), and Region - Global Forecast to 2034"
Aptamers Market is projected to grow from US$ 205.40 million in 2020 to US$ 985.44 million by 2030. Advancements in aptamer development technologies, increasing R&D expenditure, and the rising number of companies investing in this market are the major key driving factors responsible for the growth of global aptamers market. Low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systemic evolution of ligands by exponential enrichment technology (SELEX) which boosts the global market positively.
Aptamers Market was valued at US$ 2.9 Billion in 2024 and is projected to grow at a CAGR of 24.7% to reach US$ 26.6 Billion by 2034.
Key Highlights:
- In September 2018, Base Pair Biotechnologies was awarded for discovering aptamers to canine oncology biomarkers.
- In April 2019, Agilent and Somalogic sign agreement for supply of customized microarrays
Key Market Insights from the report:
Aptamers Market was valued at US$ 2.9 Billion in 2024 and is projected to grow at a CAGR of 24.7% to reach US$ 26.6 Billion by 2034.over the forecast period. The market report has been segmented on the type, application, and region.
- By type, the aptamers market is segmented into nucleic acid and peptides. The peptides is further segmented into DNA-based aptamer, RNA-based aptamers, and XNA-based aptamers.
- By application, the aptamers market is categorized into diagnostics, therapeutics and research and development.
- By region, North America is projected to lead the global aptamers market and is expected to remain dominant, due to rapid technological advancements and high investment and funding to support the development of aptamers.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Aptamers market”, By Type (Nucleic Acid and Peptides (DNA-Based Aptamers, RNA-Based Aptamers, XNA-Based Aptamers), By Application (Diagnostics, Therapeutics, and Research and Development), and by Region – forecast till 2034
The prominent player operating in the global aptamers market includes Somalogic, Inc., Noxxan Pharma AG, Aptamer Science Inc., Aptagen, Inc, AM Biotechnologies LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., TriLink BioTechnologies, Inc.
About Prophecy Market Insights
Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
U.S. 1 860 531 2574
RoW: 917775049802
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Custmoized Your ReportWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request for Discount
